1 / 4

Acne Vulgaris Market size, Drugs, Epidemiology, Pipeline and Leading Companies

DelveInsight's "Acne Vulgaris Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Acne Vulgaris , historical and forecasted epidemiology as well as the Acne Vulgaris market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<br><br>

sthakur
Télécharger la présentation

Acne Vulgaris Market size, Drugs, Epidemiology, Pipeline and Leading Companies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. DelveInsight launched its new report on Acne Vulgaris Market Insights, Epidemiology, and Market Forecast-2030. DelveInsight’s “Acne Vulgaris Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Acne Vulgaris , historical and forecasted epidemiology as well as the Acne Vulgaris market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some key facts of the report: 1. Acne Vulgaris affects ~85% of young adults aged 12–25 years. 2. Acne Vulgaris is ranked as the 8th most prevalent disease worldwide and is projected to affect approximately 9.4% of the global population. 3. Acne Vulgaris is observed to occur mostly in adolescence, but acne can persist upto the 20s and 30s in approximately 60% and 40% of individuals respectively. 4. Acne vulgaris is more common in females as compared to males.

  2. Request for sample pages: https://www.delveinsight.com/sample-request/acne-vulgaris-av- market Key benefits of the report: 1. In the coming years, Acne Vulgaris market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market 2. The companies and academics are working to assess challenges and seek opportunities that could influence Acne Vulgaris R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition 3. Major players are involved in developing therapies for Acne Vulgaris. Launch of emerging therapies will significantly impact the Acne Vulgaris market 4. A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Acne Vulgaris Acne Vulgaris is a common chronic skin disease involving blockage and/or inflammation of pilosebaceous units (hair follicles and their accompanying sebaceous gland). Moderate-to-severe inflammatory acne is characterized by the presence of nodules and cyst. Acne vulgaris (AV) is a common chronic skin disease involving blockage and/or inflammation of pilosebaceous units (hair follicles and their accompanying sebaceous gland). Acne can present as noninflammatory lesions, inflammatory lesions, or a mixture of both, affecting mostly the face but also the back and chest. AV appears during early puberty when androgenic stimulation triggers excessive production of sebum and abnormal follicular keratinization, colonization by a Gram- positive bacterium (Propionibacterium acnes) and local inflammation. Common symptoms of Acne Vulgaris are: whiteheads (closed plugged pores), blackheads (open plugged pores),small red, tender bumps (papules), pimples (pustules), large, solid, painful lumps beneath the surface of the skin (nodules), pus-filled lumps beneath the surface of the skin (cystic lesions). Based on the extent of severity of acne, Acne Vulgaris is classified as:  Mild  Moderate  Severe Request for sample pages: https://www.delveinsight.com/sample-request/acne-vulgaris-av-market Key pharma players involved in Acne Vulgaris market are: 1.Maruho 2.Boston Pharmaceuticals

  3. 3.Botanix Pharmaceuticals 4.Vyome 5.Novartis Pharmaceuticals 6.And Many More Drugs involved are: 1.CLS001 2.BOS-356 3.BTX 1503 4.VB-1953 5.LYS006 6.And Many More Request for sample pages: https://www.delveinsight.com/sample-request/acne-vulgaris-av-market Table of contents: 1. Key Insights 2. Executive Summary of Acne Vulgaris 3. Competitive Intelligence Analysis for Acne Vulgaris 4. Acne Vulgaris : Market Overview at a Glance 5. Acne Vulgaris : Disease Background and Overview 6. Patient Journey 7. Acne Vulgaris Epidemiology and Patient Population 8. Treatment Algorithm, Current Treatment, and Medical Practices 9. Unmet Needs 10. Key Endpoints of Acne Vulgaris Treatment 11. Marketed Products 12. Emerging Therapies 13. Acne Vulgaris : Seven Major Market Analysis 14. Attribute analysis 15. 7MM: Market Outlook 16. Access and Reimbursement Overview of Acne Vulgaris 17. KOL Views 18. Market Drivers 19. Market Barriers 20. Appendix 21. DelveInsight Capabilities 22. Disclaimer 23. About DelveInsight Request for Detailed TOC: https://www.delveinsight.com/sample-request/acne-vulgaris-av- market

  4. Related reports: Acne Vulgaris Pipeline Insight, 2020 Acne Vulgaris – Epidemiology Forecast to 2030 By Ankit Nigam Digital Marketing Executive

More Related